Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Breedon jumps on results, US acquisition

(Sharecast News) - Breedon surged on Wednesday as it hailed record underlying full-year results and announced the acquisition of US construction materials and surfacing solutions business Lionmark for $238m (£187m) - a deal which is expected to more than double its US revenue. Headquartered in Missouri, Lionmark has a focus on road infrastructure end markets. In the 12 months to 30 November 2024, the business recorded unaudited revenue of $246m and unaudited adjusted earnings before interest, tax, depreciation and amortisation of $31m.

Breedon said the deal is expected to be immediately earnings enhancing and will more than double its US revenue, increasing vertical-integration and diversifying its US product offering into asphalt and surfacing.

Andy Arnold, managing director of Breedon US, said: "The acquisition of Lionmark represents a significant milestone in the development of our US business.

"Lionmark is extremely complementary to our existing operations, diversifying BMC's product to supply asphalt and surfacing solutions into an attractive market which is well-positioned for future growth."

News of the acquisition came alongside results for the year to the end of December 2024, which showed that underlying EBITDA rose 11% to £269.9m, "helped by good cost control and operational self-help measures across each of the divisions".

Revenue was 6% higher at £1.58bn, supported by the company's entry into the US and price actions.

Breedon said revenue growth was more weighted to the second half, rising 3% in the first six months and 9% in the second versus the equivalent periods in 2023. The second half benefited from a full contribution from BMC Enterprises, which was acquired last year, and a modest improvement in GB trading conditions compared with 2023.

Chief executive Rob Wood said: "2024 was another successful year for Breedon. We entered the US market, delivered record revenue in the face of challenging conditions, and took care of our people.

"Entering 2025 we have three strong platforms, a first-class team, an abundance of opportunity and our markets are poised for recovery. Our refreshed Breedon 3.0 strategy means that everything we need for success is now in place and I am more excited than ever for our future."

At 0920 GMT, the shares were up 13% at 483.04p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.